scholarly journals A proof‐of‐concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug

2019 ◽  
Vol 177 (4) ◽  
pp. 769-777 ◽  
Author(s):  
John L. Wallace ◽  
Peter Nagy ◽  
Troy D. Feener ◽  
Thibault Allain ◽  
Tamás Ditrói ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Hydrogen Sulfide ◽  
Phase 2 ◽  
Proof Of Concept ◽  
Inflammatory Drug ◽  
Gastrointestinal Safety ◽  
Phase 2 Clinical Trial ◽  
Anti Inflammatory

scholarly journals Enhanced Analgesic Effects and Gastrointestinal Safety of a Novel, Hydrogen Sulfide-Releasing Anti-Inflammatory Drug (ATB-352): A Role for Endogenous Cannabinoids

2020 ◽  
Vol 33 (14) ◽  
pp. 1003-1009 ◽  
Author(s):  
Soraia K.P.F. Costa ◽  
Marcelo N. Muscara ◽  
Thibault Allain ◽  
Jorge Dallazen ◽  
Larissa Gonzaga ◽  
...  
Keyword(s):  
Hydrogen Sulfide ◽  
Inflammatory Drug ◽  
Analgesic Effects ◽  
Gastrointestinal Safety ◽  
Endogenous Cannabinoids ◽  
Anti Inflammatory

Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

2019 ◽  
Vol 3 ◽  
pp. S9
Author(s):  
Zoe Draelos ◽  
Fran Cook-Bolden ◽  
Lawrence Green ◽  
Eric Guenin ◽  
Gina Martin ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Patient Reported Outcomes ◽  
Phase 2 ◽  
Patient Reported ◽  
Phase 2 Clinical Trial

Abstract not available.

Sign in / Sign up

Export Citation Format

Share Document